FIELD: medicine.
SUBSTANCE: drug contains polyhexamethyleneguanidine phosphate as a reactant and an effervescent complex containing major and acid components, specifically anhydrous sodium carbonate and citric or tartaric acid. The drug is granulated or tableted and characterised with consistent qualitative and quantitative reactant content within 2-year storage life.
EFFECT: does not develop acute and chronic toxicity, ensured high antifungal and antiseptic activity, accessible.
9 cl, 2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RAPIDLY DISSOLVING DOSAGE FORM OF FURAZOLIDONE AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2772430C1 |
| INSTANTLY SOLUBLE DOSAGE FORM OF METRONIDAZOLE AND METHOD OF ITS OBTAINING (VERSIONS) | 2021 |
|
RU2797947C2 |
| RAPIDLY DISSOLVING PHARMACEUTICAL FORM OF INDOMETHACIN AND METHOD FOR PRODUCTION THEREOF (VARIANTS) | 2020 |
|
RU2764032C1 |
| METHOD FOR PREPARING COMPOSITION AS CARBONATED TABLET | 2003 |
|
RU2257891C1 |
| IMMUNOSTIMULATING DRUG AND METHOD FOR PREPARING IT | 2008 |
|
RU2432171C2 |
| SOLID MEDICINAL FORM OF TERBINAFINE HYDROCHLORIDE | 2001 |
|
RU2200003C1 |
| ANTACID AND METHODS FOR PRODUCING IT (VERSIONS) | 2013 |
|
RU2567800C2 |
| GEL FOR TREATMENT OF BACTERIAL CONJUNCTIVITIS (VARIANTS) | 2003 |
|
RU2240107C1 |
| ANTIMICROBIAL MEDICINAL PREPARATION IN THE FORM OF TABLETS OF FURACILIN WITH ACCELERATED RELEASE | 2019 |
|
RU2696573C1 |
| METHOD FOR PRODUCTION OF CLOZAPINE PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS AND PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2441651C1 |
